• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

穿透素修饰叶黄素纳米乳凝胶治疗年龄相关性黄斑变性。

Penetratin-modified lutein nanoemulsion gel for the treatment of age-related macular degeneration.

机构信息

Department of Pharmaceutics, College of Pharmacy, Shenyang Pharmaceutical University, Shenyang, Liaoning, PR China.

Department of Pharmacy, Fuwai Hospital Chinese Academy of Medical Sciences, Shenzhen, PR China.

出版信息

Expert Opin Drug Deliv. 2020 Apr;17(4):603-619. doi: 10.1080/17425247.2020.1735348. Epub 2020 Mar 9.

DOI:10.1080/17425247.2020.1735348
PMID:32105151
Abstract

: Lutein is the primary macular pigment with an favorable effect on the treatment of age-related macular degeneration (AMD). However, the poor water solubility of lutein hinders its absorption and delivery. In this study, a penetratin-modified lutein nanoemulsion gel (GEL) was prepared for the treatment of AMD.: A nanoemulsion (NE) was prepared and modified with penetratin (P-NE) to improve the penetration. The effect of penetratin was evaluated by cell uptake and intraocular distribution assays. A dry AMD model was induced using NaIO, and the therapeutic effect was evaluated by electroretinography, the number of apoptosis cells and the reactive oxygen species (ROS) level.: Lutein showed a good ability to protect ARPE-19 from the damage of HO and the uptake rate of P-NE was significantly higher than NE. In the efficacy experiments, the structure of retina was significantly improved after treatment, the apoptosis rate decreased from 31.98% to 2.05%, and the level of ROS was significantly decreased ( < 0.0001).: With the aid of penetratin, lutein could be delivered to the retina effectively. The P-NE GEL could evidently inhibit the apoptosis and ROS, demonstrating that the P-NE GEL has a good application prospect in the treatment of AMD.

摘要

叶黄素是主要的黄斑色素,对治疗年龄相关性黄斑变性(AMD)有良好的效果。然而,叶黄素的水溶性差阻碍了其吸收和传递。在这项研究中,制备了一种穿透肽修饰的叶黄素纳米乳凝胶(GEL),用于治疗 AMD。

制备了纳米乳(NE)并通过穿透肽(P-NE)进行修饰以提高穿透性。通过细胞摄取和眼内分布试验评估穿透肽的效果。使用 NaIO 诱导干性 AMD 模型,并通过视网膜电图、凋亡细胞数量和活性氧(ROS)水平评估治疗效果。

叶黄素显示出良好的保护 ARPE-19 免受 HO 损伤的能力,并且 P-NE 的摄取率明显高于 NE。在疗效实验中,经治疗后视网膜结构明显改善,凋亡率从 31.98%降至 2.05%,ROS 水平显著降低(<0.0001)。

在穿透肽的辅助下,叶黄素可以有效地递送到视网膜。P-NE GEL 可以明显抑制细胞凋亡和 ROS,表明 P-NE GEL 在治疗 AMD 方面具有良好的应用前景。

相似文献

1
Penetratin-modified lutein nanoemulsion gel for the treatment of age-related macular degeneration.穿透素修饰叶黄素纳米乳凝胶治疗年龄相关性黄斑变性。
Expert Opin Drug Deliv. 2020 Apr;17(4):603-619. doi: 10.1080/17425247.2020.1735348. Epub 2020 Mar 9.
2
Ultra-small-size Astragaloside-IV loaded lipid nanocapsules eye drops for the effective management of dry age-related macular degeneration.载有超小尺寸黄芪甲苷的脂质纳米胶囊滴眼液,用于有效治疗与年龄相关的干性黄斑变性。
Expert Opin Drug Deliv. 2020 Sep;17(9):1305-1320. doi: 10.1080/17425247.2020.1783236. Epub 2020 Jun 30.
3
Improvement of retinal function in early age-related macular degeneration after lutein and zeaxanthin supplementation: a randomized, double-masked, placebo-controlled trial.叶黄素和玉米黄质补充剂对早发性年龄相关性黄斑变性视网膜功能的改善:一项随机、双盲、安慰剂对照试验。
Am J Ophthalmol. 2012 Oct;154(4):625-634.e1. doi: 10.1016/j.ajo.2012.04.014. Epub 2012 Jul 25.
4
Effect of lutein and zeaxanthin on macular pigment and visual function in patients with early age-related macular degeneration.叶黄素和玉米黄质对早期年龄相关性黄斑变性患者黄斑色素和视觉功能的影响。
Ophthalmology. 2012 Nov;119(11):2290-7. doi: 10.1016/j.ophtha.2012.06.014. Epub 2012 Aug 1.
5
Changes following supplementation with lutein and zeaxanthin in retinal function in eyes with early age-related macular degeneration: a randomised, double-blind, placebo-controlled trial.叶黄素和玉米黄质补充剂对早期年龄相关性黄斑变性患者视网膜功能的影响:一项随机、双盲、安慰剂对照试验
Br J Ophthalmol. 2015 Mar;99(3):371-5. doi: 10.1136/bjophthalmol-2014-305503. Epub 2014 Sep 16.
6
Protection effect of lutein-loaded Pickering emulsion prepared ultrasound-assisted Maillard reaction conjugates on dry age-related macular degeneration.叶黄素负载 Pickering 乳液的保护作用——超声辅助美拉德反应缀合物对干性年龄相关性黄斑变性的作用。
Food Funct. 2024 Jun 17;15(12):6347-6358. doi: 10.1039/d4fo00673a.
7
Reactive oxygen species-dependent mitochondrial dynamics and autophagy confer protective effects in retinal pigment epithelial cells against sodium iodate-induced cell death.活性氧依赖的线粒体动力学和自噬赋予视网膜色素上皮细胞对抗碘酸钠诱导的细胞死亡的保护作用。
J Biomed Sci. 2019 May 22;26(1):40. doi: 10.1186/s12929-019-0531-z.
8
Protective effects of PARP1-inhibitory compound in dry age-related macular degeneration.PARP1 抑制剂化合物在干性年龄相关性黄斑变性中的保护作用。
Biomed Pharmacother. 2021 Jan;133:111041. doi: 10.1016/j.biopha.2020.111041. Epub 2020 Dec 2.
9
Intravitreal injection of docosahexaenoic acid attenuated photoreceptor cell injury in a NaIO-induced age-related macular degeneration rat model.玻璃体内注射二十二碳六烯酸可减轻在碘酸钠诱导的年龄相关性黄斑变性大鼠模型中的光感受器细胞损伤。
Neurosci Lett. 2017 Sep 14;657:53-61. doi: 10.1016/j.neulet.2017.07.041. Epub 2017 Jul 25.
10
Lutein and zeaxanthin for macular degeneration.叶黄素和玉米黄质用于黄斑变性。
Am J Health Syst Pharm. 2008 Jul 1;65(13):1232-8. doi: 10.2146/ahjp080052.

引用本文的文献

1
Topical Ocular Drug Delivery: The Impact of Permeation Enhancers.眼部局部给药:渗透促进剂的影响
Pharmaceutics. 2025 Mar 31;17(4):447. doi: 10.3390/pharmaceutics17040447.
2
Utilization of Nanoparticles for Treating Age-Related Macular Degeneration.纳米颗粒在治疗年龄相关性黄斑变性中的应用
Pharmaceuticals (Basel). 2025 Jan 25;18(2):162. doi: 10.3390/ph18020162.
3
Recent updates on drug delivery approaches for improved ocular delivery with an insight into nanostructured drug delivery carriers for anterior and posterior segment disorders.
药物递送方法的最新进展,以改善眼部递送,并深入了解用于眼前节和眼后节疾病的纳米结构药物递送载体。
Drug Deliv Transl Res. 2025 Jun;15(6):1828-1876. doi: 10.1007/s13346-024-01756-x. Epub 2024 Dec 14.
4
Expanding Arsenal against Ocular Diseases through Nanoemulsion: Success So Far and the Road Ahead.通过纳米乳剂扩展抗眼部疾病的武器库:迄今为止的成功与未来之路。
Curr Drug Deliv. 2024 Jul 15. doi: 10.2174/0115672018286288240705064730.
5
Nutraceuticals for Diabetic Retinopathy: Recent Advances and Novel Delivery Systems.用于糖尿病视网膜病变的营养药物:最新进展与新型传递系统。
Nutrients. 2024 May 30;16(11):1715. doi: 10.3390/nu16111715.
6
Reactive oxygen species-scavenging nanomaterials for the prevention and treatment of age-related diseases.用于预防和治疗与年龄相关疾病的活性氧清除纳米材料。
J Nanobiotechnology. 2024 May 15;22(1):252. doi: 10.1186/s12951-024-02501-9.
7
OCTN2- and ATB-targeted nanoemulsions for improving ocular drug delivery.OCTN2 和 ATB 靶向的纳米乳液用于改善眼部药物传递。
J Nanobiotechnology. 2024 Mar 26;22(1):130. doi: 10.1186/s12951-024-02402-x.
8
Recent Advances in Nanomedicine for Ocular Fundus Neovascularization Disease Management.纳米医学在眼部眼底新生血管疾病管理中的最新进展。
Adv Healthc Mater. 2024 Jul;13(17):e2304626. doi: 10.1002/adhm.202304626. Epub 2024 Mar 10.
9
Next generation therapeutics for retinal neurodegenerative diseases.视网膜神经退行性疾病的下一代治疗方法。
J Control Release. 2024 Mar;367:708-736. doi: 10.1016/j.jconrel.2024.01.063. Epub 2024 Feb 10.
10
Anti-VEGF Drugs in Age-Related Macular Degeneration: A Focus on Dosing Regimen-Related Safety and Efficacy.抗血管内皮生长因子药物在年龄相关性黄斑变性中的应用:关注与剂量方案相关的安全性和疗效。
Drugs Aging. 2023 Nov;40(11):991-1007. doi: 10.1007/s40266-023-01068-8. Epub 2023 Oct 20.